cdp 840 has been researched along with Vomiting in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Djuric, S; Hanney, B; He, W; Huang, FC; Liang, G; Mason, J; Miller, B; Souness, J | 1 |
Huang, Z; Laliberté, F; Liu, S; Macdonald, D; Masson, P; Perrier, H; Rasori, R; Robichaud, A | 1 |
Ball, RG; Blouin, M; Boulet, L; Côté, B; Ducharme, Y; Frenette, R; Friesen, RW; Girard, M; Girard, Y; Guay, D; Huang, Z; Jones, TR; Laliberté, F; Lynch, JJ; Mancini, J; Martins, E; Masson, P; Muise, E; Pon, DJ; Siegl, PK; Styhler, A; Tsou, NN; Turner, MJ; Young, RN | 1 |
Bateman, K; Boulet, L; Chan, CC; Charleson, S; Chauret, N; Claveau, D; Day, S; Deschênes, D; Dubé, D; Ethier, D; Gallant, M; Girard, Y; Huang, Z; Lacombe, P; Laliberté, F; Li, C; Liu, S; Macdonald, D; Mancini, J; Masson, P; Mastracchio, A; Muise, E; Nicholson, D; Nicoll-Griffith, DA; Perrier, H; Pon, D; Roy, B; Scheigetz, J; Silva, JM; Styhler, A; Trimble, LA; Turner, M; Young, RN | 1 |
Akuta, K; Hirose, R; Ichimura, M; Manabe, H; Nonaka, H; Ohshima, E; Sato, S; Yanagawa, K | 1 |
5 other study(ies) available for cdp 840 and Vomiting
Article | Year |
---|---|
Novel cyclic compounds as potent phosphodiesterase 4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Brain; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Endotoxemia; Female; Guinea Pigs; In Vitro Techniques; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Phosphodiesterase Inhibitors; Pyridines; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Vomiting | 1998 |
Hunting the emesis and efficacy targets of PDE4 inhibitors: identification of the photoaffinity probe 8-(3-azidophenyl)-6- [(4-iodo-1H-1-imidazolyl)methyl]quinoline (APIIMQ).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Asthmatic Agents; Azides; Bronchoconstriction; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 4; Enzyme Inhibitors; Ferrets; Guinea Pigs; Humans; Photoaffinity Labels; Quinolines; Recombinant Fusion Proteins; Tumor Necrosis Factor-alpha; Vomiting | 2000 |
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alcohols; Animals; Bronchoconstriction; Crystallography, X-Ray; Cyclic N-Oxides; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Electrocardiography; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Humans; In Vitro Techniques; Long QT Syndrome; Phosphodiesterase Inhibitors; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Pyridines; Rats; Saimiri; Sheep; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Vomiting | 2003 |
Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bronchoconstriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Humans; Inhibitory Concentration 50; Phosphodiesterase Inhibitors; Quinolines; Rats; Saimiri; Sheep; Structure-Activity Relationship; Vomiting | 2005 |
Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
Topics: Animals; Benzamides; Binding Sites; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Kinetics; Male; Molecular Structure; Naphthyridines; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rolipram; Shrews; Tritium; Vomiting; Xanthines | 2007 |